These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 26259900)

  • 41. Antimony resistance and gene expression in
    Madusanka RK; Karunaweera ND; Silva H; Selvapandiyan A
    Parasitology; 2024 Jan; 151(1):1-14. PubMed ID: 38012864
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evolution, function and roles in drug sensitivity of trypanosome aquaglyceroporins.
    Quintana JF; Field MC
    Parasitology; 2021 Sep; 148(10):1137-1142. PubMed ID: 33602349
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Instability of aquaglyceroporin (AQP) 2 contributes to drug resistance in Trypanosoma brucei.
    Quintana JF; Bueren-Calabuig J; Zuccotto F; de Koning HP; Horn D; Field MC
    PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008458. PubMed ID: 32644992
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular Analysis of
    Alijani Y; Hosseini SS; Ahmadian S; Boughattas S; Eslami G; Naderian S; Ajamein V
    J Arthropod Borne Dis; 2019 Jun; 13(2):145-152. PubMed ID: 31803775
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Functional role of lysine 12 in Leishmania major AQP1.
    Sharma M; Mandal G; Mandal S; Bhattacharjee H; Mukhopadhyay R
    Mol Biochem Parasitol; 2015 Jun; 201(2):139-45. PubMed ID: 26259900
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of alanine 163 in solute permeability of Leishmania major aquaglyceroporin LmAQP1.
    Mukhopadhyay R; Mandal G; Atluri VS; Figarella K; Uzcategui NL; Zhou Y; Beitz E; Ajees AA; Bhattacharjee H
    Mol Biochem Parasitol; 2011 Jan; 175(1):83-90. PubMed ID: 20888371
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biochemical characterization of Leishmania major aquaglyceroporin LmAQP1: possible role in volume regulation and osmotaxis.
    Figarella K; Uzcategui NL; Zhou Y; LeFurgey A; Ouellette M; Bhattacharjee H; Mukhopadhyay R
    Mol Microbiol; 2007 Aug; 65(4):1006-17. PubMed ID: 17640270
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modulation of Leishmania major aquaglyceroporin activity by a mitogen-activated protein kinase.
    Mandal G; Sharma M; Kruse M; Sander-Juelch C; Munro LA; Wang Y; Vilg JV; Tamás MJ; Bhattacharjee H; Wiese M; Mukhopadhyay R
    Mol Microbiol; 2012 Sep; 85(6):1204-18. PubMed ID: 22779703
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Generation of an aquaglyceroporin AQP1 null mutant in Leishmania major.
    Plourde M; Ubeda JM; Mandal G; Monte-Neto RL; Mukhopadhyay R; Ouellette M
    Mol Biochem Parasitol; 2015 Jun; 201(2):108-11. PubMed ID: 26222914
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Species-specific antimonial sensitivity in Leishmania is driven by post-transcriptional regulation of AQP1.
    Mandal G; Mandal S; Sharma M; Charret KS; Papadopoulou B; Bhattacharjee H; Mukhopadhyay R
    PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003500. PubMed ID: 25714343
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intrinsic disorder drives N-terminal ubiquitination by Ube2w.
    Vittal V; Shi L; Wenzel DM; Scaglione KM; Duncan ED; Basrur V; Elenitoba-Johnson KS; Baker D; Paulson HL; Brzovic PS; Klevit RE
    Nat Chem Biol; 2015 Jan; 11(1):83-9. PubMed ID: 25436519
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aquaglyceroporins: generalized metalloid channels.
    Mukhopadhyay R; Bhattacharjee H; Rosen BP
    Biochim Biophys Acta; 2014 May; 1840(5):1583-91. PubMed ID: 24291688
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Proteasome inhibitor MG132 enhances TRAIL-induced apoptosis and inhibits invasion of human osteosarcoma OS732 cells.
    Li X; Huang T; Jiang G; Gong W; Qian H; Zou C
    Biochem Biophys Res Commun; 2013 Sep; 439(2):179-86. PubMed ID: 23994633
    [TBL] [Abstract][Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.